Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-03-22
2005-03-22
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
Reexamination Certificate
active
06869777
ABSTRACT:
The present invention relates to compositions and methods for expressing mini-dystrophin peptides. In particular, the present invention provides compositions comprising nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins. The present invention also provides compositions comprising mini-dystrophin peptides, and methods for expressing mini-dystrophin peptides in target cells.
REFERENCES:
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5239060 (1993-08-01), Kunkel et al.
patent: 5260209 (1993-11-01), Campbell et al.
patent: 5308752 (1994-05-01), Campbell et al.
patent: 5430129 (1995-07-01), Campbell et al.
patent: 5449616 (1995-09-01), Campbell et al.
patent: 5541074 (1996-07-01), Kunkel et al.
patent: 5621091 (1997-04-01), Kunkel et al.
patent: 5686073 (1997-11-01), Campbell et al.
patent: 5863743 (1999-01-01), Campbell et al.
patent: 1059354 (2000-06-01), None
patent: WO 8806630 (1988-07-01), None
patent: WO 9002909 (1992-02-01), None
patent: WO 9722696 (1997-06-01), None
patent: WO0183695 (2001-08-01), None
Davison MD, Baron MD, Critchley DR, Wootton JC. Structural analysis of homologous repeated domains in alpha-actinin and spectrin.Int J Biol Macromol. 1989 Apr.;11(2):81-90.*
Yausa et al. (including Shinichi Takeda), FEBS Letters 425:329-336, 1998.
Wang et al. (including Xiao Xiao) PNAS, 97(25):13714-13719, Dec. 5, 2000.
Phelps et al., Hum. Mol. Gen.; 4(8):1251-1258 (1995).
Hauser and Chamberlain, J. of Endocrinology, 149:373-378 (1996).
Rafael et al., Hum. Mol. Gen., 3(10):1725-1733 (1994).
Cox et al., Nature, 364:725-729 (1993).
Hartigan-O'Conner and Chamberlain, Microscopy Research and Technique, 48:223-238 (Feb., 2000).
Wells et al., Hum. Mol. Genet, 4(8):1245-50 (1995).
Corrado et al., FEBS Letters, 344:255-260 [1994].
Jung et al.,JBC, 270 (45):27305 [1995].
Blake et al., Brain Pathology, 6:37 [1996].
Winder, J. Muscle Res. Cell. Motil., 18:617 [1997].
Tinsley et al., PNAS, 91:8307 [1994].
Winder et al.,Febs Letters, 369:27-33 (1995).
Dhermy, 1991. Biol. Cell, 71:249-254.
Speicher and Ursitti, Current Biology, 4:154 [1994].
Yan et al., Science, 262-2027 [1993].
Matsudaira, Trends Biochem Scri, 16:87 [1991].
Speicher and Marchesi, Nature, 311:177 [1984].
Love et al.,Nature339-55 [1989].
Winkler et al., Eur. J. Biochem., 248:193 [1997].
Stryer (ed.),Biochemistry, 2nd ed, WH Freeman and Co. [1981].
Narang, Tetrahedron Lett, 39:3 9 [1983].
Itakura et al., Recombinant DNA, in Walton (ed.),Proceedings of the 3rd Cleveland Symposium on Macromolecules, Elsevier, Amsterdam, pp 273-289 [1981].
Itakura et al., Annu. Rev. Biochem., 53:323 [1984].
Itakura et al., Science 198:1056 [1984].
Ike et al., Nucl. Acid Res., 11:477 [1983].
Scott et al., Science, 249:386-390 [1980].
Roberts et al., Proc. Natl. Acad. Sci. USA, 89:2429-2433 [1992].
Devlin et al., Science, 249: 404-406 [1990].
Cwirla et al., Proc. Natl. Acad. Sci. USA, 87: 6378-6382 [1990].
Fuchs et al., BioTechnol., 9:1370 [1991].
Goward et al., TIBS 18:136 [1992].
Marks et al., J. Biol. Chem., 267:16007 [1992].
Griffths et al., EMBO J., 12:725 [1993].
Clackson et al., Nature, 352:624 [1991].
Barbas et al., Proc. Natl. Acad. Sci., 89:4457 [1992].
Ruf et al., Biochem., 33:1565 [1994].
Wang et al., J. Biol. Chem., 269:3095 [1994].
Balint et al. Gene 137:109 [1993].
Grodberg et al., Eur. J. Biochem., 218:597 [1993].
Nagashima et al., J. Biol. Chem., 268:2888 [1993].
Lowman et al., Biochem., 30:10832 [1991].
Cunningham et al., Science, 244:1081 [1989].
Gustin et al., Virol., 193:653 [1993].
Brown et al., Mol. Cell. Biol., 12:2644 [1992].
McKnight et al., Science, 21732:316 (1982).
Meyers et al., Biochemistry 30:7666-7672 [1991].
Blake et al.,Trends Biochem. Sci., 20:133, 1995).
Sadoulet-Puccio et al.,PNAS, 94:12413, 1997).
Grady et al.,Nat. Cell. Biol, 1:215, 1999).
Rafael et al.,Hum. Mol. Genet., 3:1725, 1994.
Rafael et al.,J. Cell Biol., 134:93 1996).
Shield, et al.,Mol. Cell. Biol., 16:5058 (1996).
Trask, et al.,Nucleic Acids Res., 20:2313 (1992).
Amalfitano et al., “Production and Characterization of Improved Adenovirus Vectors With the E1, E2b, and E3 Genes Deleted,” J. Virol. 72:926-933 (1998).
Kumar-Singh et al,Hum. Mol. Genet., 5:913 (1996).
Fisher et al. “Recombinant Adenovirus Deleted of All Viral Genes for Gene Therapy of Cystic Fibrosis,”Virology217:11-22 (1996).
Kochanek et al, “A New Adenoviral Vector: Replacement of All Viral Coding Sequences With 28 kb of DNA Independently Expressing Both Full-length Dystrophin and Beta-galactosidase”Proc. Nat. Acad. Sci. USA93:5731-5736 (1996).
Hardy et al., “Construction of Adenovirus Vectors Through Cre-lox Recombination,” J. Virol. 71:1842-1849 (1997).
Hartigan-O'Conner et al., “Improved Production of Gutted Adenovirus in Cells Expressing Adenovirus Preterminal Protein and DNA Polymerase,”J. Virol. 73:7835-7841 (1999).
Yan et al.,PNAS, 97:6716-6721, 2000).
Fisher, et al.,J. Virol. 70:520-532, 1996).
Duan, et al.,Virus Res. 48:41-56, 1997).
Brennan, et al.,J. Biol. Chem. 268:719, 1993).
MacGregor and Caskey, Nuc. Acid. Res., 17:2365, 1989).
Cox et al.,Nat. Genet., 8:333-339, 1994).
Straub et al.,J. Cell. Biol., 139:375-385, 1997).
Duclos et al.,J. Cell. Biol., 142:1461, 1998.
Lynch et al.,Am. J. Physiol., 272:C2063, 1997).
Ohlendieck et al.,J. Cell. Biol., 112:135, 1991).
Matsuda et al.,J. Biochem. (Tokyo), 118:959, 1995).
Torres and Duchen,Brain, 110:269, 1987.
Ohlendieck et al., Neuron, 7:499-508, 1991).
Hauser et al.,Mol Ther., 2:16-25, 2000.
Crawford et al.,J. Cell. Biol., 150:1399, 2000.
Niwa et al.,Genes Dev. 4:1552, 1990).
Petrof, et al.,Proc. Natl. Acad. Sci. USA. 90:3710-3714, 1993.
England et al., Nature (London), 343(6254):180-182 (1990).
Clemens et al., Human Gene Therapy, 6:1477-1485 (1995).
Ascadi et al., Nature (London) 352(6338)85-818 (1991).
Amalfitano et al., Gene, Protein and Cell Biology, 1997, pp. 1-26, Cambridge University Press, ISBN, 0-521-55033-5.
U.S. Appl. No. 60/200,777, filed Apr. 28, 2000, Xiaoel et al.
Chamberlain Jeffrey S.
Harper Scott Q.
Carlson Karen Cochrane
Hedlen & Carroll, LLP
Regents of the University of Michigan
Snedden Sheridan
LandOfFree
Mini-dystrophin nucleic acid sequences does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mini-dystrophin nucleic acid sequences, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mini-dystrophin nucleic acid sequences will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3368142